Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 18419884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tuberculosis morbidity in the U.S. Navy: its distribution and decline.

  2015cited by this paper
• Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service.

  2015cited by this paper
• Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchMenzies D, Pai M, Comstock G (McGill Univ, Montreal; Johns Hopkins Univ, Baltimore, Md) Ann Intern Med 146:340–354, 2007§

  2008cited by this paper
• U.S. medical resident familiarity with national tuberculosis guidelines

  2007cited by this paper
• False-positive tuberculin reactions due to non-tuberculous mycobacterial infections.

  2007cited by this paper
• False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?

  2006cited by this paper
• Using computerized clinical decision support for latent tuberculosis infection screening.

  2005cited by this paper
• Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.

  2005cited by this paper
• Priorities for the treatment of latent tuberculosis infection in the United States.

  2004cited by this paper
• Yield of casual contact investigation by the hour.

  2003cited by this paper
• Yield of casual contact investigation by the hour.

  2003cited by this paper
• Smoking and tuberculosis: an association overlooked.

  2002cited by this paper
• Tuberculosis in patients with end-stage renal disease.

  2001cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

  2001cited by this paper
• Guided medication dosing for inpatients with renal insufficiency.

  2001cited by this paper
• Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis.

  2000cited by this paper
• Risk Factors for Developing Tuberculosis in HIV‐1‐Infected Adults From Communities With a Low or Very High Incidence of Tuberculosis

  2000cited by this paper
• Epidemiologic basis of tuberculosis control

  1999cited by this paper
• Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

  1999cited by this paper
• Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

  1997cited by this paper
• The epidemiology of tuberculosis in the United States.

  1997cited by this paper
• The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.

  1997cited by this paper
• The high incidence of tuberculosis among renal transplant recipients in India.

  1996cited by this paper
• Incidence of pulmonary tuberculosis among diabetics.

  1995cited by this paper
• Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study

  1995cited by this paper
• Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).

  1995cited by this paper
• Mycobacterium tuberculosis in lung transplant recipients.

  1995cited by this paper
• Tuberculosis in liver transplant patients.

  1994cited by this paper
• The epidemiology of tuberculosis in gold miners with silicosis.

  1994cited by this paper
• A prospective study of the risk of tuberculosis among HIV‐infected patients

  1993cited by this paper
• A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.

  1992cited by this paper
• A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

  1989cited by this paper
• Epidemiology of tuberculosis in the United States.

  1989cited by this paper
• Contact screening procedures for tuberculosis in Auckland.

  1988cited by this paper
• Tuberculosis in a cohort of Southeast Asian Refugees. A five-year surveillance study.

  1988cited by this paper
• Contact screening procedures for tuberculosis in Auckland.

  1988cited by this paper
• Tuberculin sensitivity.

  1987cited by this paper
• Tuberculosis in maintenance haemodialysis patients. Study from an endemic area.

  1981cited by this paper
• Tuberculosis in patients with end-stage renal disease.

  1980cited by this paper
• Tuberculosis in patients undergoing maintenance hemodialysis.

  1979cited by this paper
• Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.

  1976cited by this paper
• Tuberculin sensitivity. Contacts of tuberculosis patients.

  1976cited by this paper
• Tuberculin sensitivity. Contacts of tuberculosis patients.

  1976cited by this paper
• Contacts of cases of active pulmonary tuberculosis.

  1975cited by this paper
• Frost revisited: the modern epidemiology of tuberculosis.

  1975cited by this paper
• Results of contact examination in Rotterdam, 1967-1969.

  1975cited by this paper
• Tuberculosis in dialyzed patients.

  1974cited by this paper
• Identification of tuberculous infected. Dual tests and density of reaction.

  1973cited by this paper
• Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area.

  1969cited by this paper
• Identifying the tuberculous infected. The dual-test technique.

  1968cited by this paper
• Reactivations in Inactive Pulmonary Tuberculosis1, 2

  1966cited by this paper
• [Diabetes mellitus and pulmonary tuberculosis].

  1961cited by this paper
• The influence of the number of bacilli on the development of tuberculous disease in children.

  1960cited by this paper
• Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity.

  1959cited by this paper
• Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county.

  1958cited by this paper
• Diabetes mellitus and pulmonary tuberculosis.

  1957cited by this paper
• Reactivation of inactive pulmonary tuberculosis.

  1956cited by this paper

• Prevalence, Conversion and Reversion of Tuberculosis Infection Among Healthcare Workers of Tertiary Care Centres in Puducherry, India: A Prospective Cohort Study

  2025cites this paper
• Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification

  2025cites this paper
• Tuberculosis risk in immunosuppressed patients: Revisiting an old acquaintance

  2025cites this paper
• The role of chest X-ray in detecting latent tuberculosis among patients with low-risk inflammatory bowel disease before advanced therapy

  2025cites this paper
• Multidrug-resistant tuberculosis

  2024cites this paper
• Infectious Disease Prophylaxis During and After Immunosuppressive Therapy

  2024cites this paper
• Riesgo de tuberculosis en pacientes con inmunosupresión: en búsqueda de una vieja conocida

  2024cites this paper
• Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.

  2024cites this paper
• Chapitre 4: Le diagnostic de l’infection tuberculeuse

  2023cites this paper
• Tests cutanés à la tuberculine et tests de libération de l’interféron γ pour le diagnostic de l’infection tuberculeuse

  2023cites this paper
• Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection

  2023cites this paper
• Know your tuberculosis epidemic–Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?

  2022cites this paper
• Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada

  2022cites this paper
• Chapter 4: Diagnosis of tuberculosis infection

  2022cites this paper
• Estimation of the Prevalence of Latent TB Infection in a wholesale perishable market Complex in Chennai and assessment of risk factors for the progression of LTBI to Active TB Disease- Research Protocol

  2022cites this paper
• Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection

  2021cites this paper
• Build back better: Advances in tuberculosis research in Canada & globally in 2020

  2021cites this paper
• Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study

  2020cites this paper
• A clinical audit and cost analysis of latent TB management at a tertiary referral centre in Ireland

  2020cites this paper
• Use of tuberculin skin test, chest radiograph and interferon-gamma release assay to select migrants for treatment of latent tuberculosis.

  2020cites this paper
• Diagnostic methods of tuberculosis.

  2020cites this paper
• Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

  2020cites this paper
• How well does TSTin3D predict risk of active tuberculosis in the Canadian immigrant population? An External Validation Study.

  2020influential citation
• Diagnostic methods of tuberculosis

  2020cites this paper
• A new mathematical model to identify contacts with recent and remote latent tuberculosis

  2019cites this paper
• Precision immunoprofiling to reveal diagnostic signatures for latent tuberculosis infection and reactivation risk stratification.

  2019cites this paper
• Treatment of Latent Tuberculosis Infection-An Update.

  2019cites this paper
• Prevalence and Risk Factors of Latent Tuberculosis Infection among Healthcare Workers

  2019cites this paper
• Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.

  2019cites this paper
• Clinical Characteristics of Active Tuberculosis Diagnosed after Starting Treatment for Latent Tuberculosis Infection.

  2019cites this paper
• Diagnostic Tests for Latent Tuberculosis Infection.

  2019cites this paper
• Latent Tuberculosis Infection: Patho-Biology and Treatment

  2018cites this paper
• Prevalence of latent Mycobacterium tuberculosis infection in renal transplant recipients

  2018cites this paper
• Tuberculosis associated with tumor necrosis factor-α antagonists, case description and analysis of reported cases in Colombia.

  2018cites this paper
• Interpretation des Tuberkulose- und Hepatitisscreenings vor immunsuppressiver Therapie

  2018cites this paper
• A scoring strategy for progression risk and rates of treatment completion in subjects with latent tuberculosis

  2018cites this paper
• Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence

  2017influential citation
• Prevalence of tuberculosis infection in healthcare workers of the public hospital network in Medellín, Colombia: a Bayesian approach

  2017cites this paper
• Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations.

  2017cites this paper
• Preventive therapy for latent tuberculosis infection-the promise and the challenges.

  2017influential citation
• Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.

  2017cites this paper
• Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.

  2017cites this paper
• Immunological characterization of latent tuberculosis infection in a low endemic country.

  2017cites this paper
• Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity

  2017cites this paper
• Interpreting diagnostic tests with continuous results and no gold standard: a common scenario explained using the tuberculin skin test

  2017cites this paper
• Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates

  2017cites this paper
• Use of a scoring strategy to determine clinical risk of progression and risk group-specific treatment adherence in subjects with latent tuberculosis infection

  2017cites this paper
• Estudio de la utililidad del test IGRA (Quantiferón TB gold) en un hospital general

  2016cites this paper
• Prevalence of latent Mycobacterium tuberculosis infection in prisoners

  2016cites this paper
• Gestión de riesgo para la prescripción de terapias biológicas

  2016cites this paper
• Ocular manifestations of tuberculosis: an update

  2016cites this paper
• Risk management for prescribing biological therapies

  2016cites this paper
• Benefit of treatment of latent tuberculosis infection in individual patients

  2016cites this paper
• Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays

  2016cites this paper
• Interferon Gamma Release Assays in Denmark, population-based studies from a tuberculosis low-incidence country

  2016cites this paper
• Diagnosis of latent Mycobacterium tuberculosis infection: tuberculin test versus interferon-gamma release.

  2015cites this paper
• Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification.

  2015cites this paper
• Treatment of Latent Tuberculosis Infection

  2015cites this paper
• Benefit of treatment of latent tuberculosis infection in individual patients

  2015cites this paper
• Role of QuantiFERON®-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit

  2015cites this paper
• What Every Hospitalist Should Know

  2014cites this paper
• HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study

  2014cites this paper
• Revista6Vol89ingles_Layout 1

  2014cites this paper
• Update on cutaneous tuberculosis

  2014cites this paper
• Canadian Tuberculosis Standards

  2014cites this paper
• Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

  2014influential citation
• NEW ADVANCES IN DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION: A REVIEW ARTICLE

  2014cites this paper
• Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010.

  2014cites this paper
• Tuberculosis: What Every Hospitalist Should Know

  2014cites this paper
• Erythema nodosum, a “red flag” during anti‐TNF therapy

  2013cites this paper
• UNIVERSIDADE FEDERAL DO ESPÍRITO SANTO CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM SAÚDE COLETIVA - PPGSC MESTRADO EM SAÚDE COLETIVA

  2013cites this paper
• Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON®-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination

  2013cites this paper
• Case records of the Massachusetts General Hospital. Case 3-2013. A 72-year-old woman with abdominal pain and distention after peritoneal dialysis.

  2013cites this paper
• A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.

  2013cites this paper
• Infection Detection of Mycobacterium tuberculosis Gamma Interferon Release Assays for

  2013influential citation
• Prophylaxis for Latent Tuberculosis Infection Prior to Anti–Tumor Necrosis Factor Therapy in Low‐Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis

  2013cites this paper
• Managing and monitoring tuberculosis using web-based tools in combination with traditional approaches

  2013cites this paper
• Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence

  2013cites this paper
• Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil

  2013influential citation
• What Patient Factors Predict Physicians’ Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?

  2013cites this paper
• Intraocular tuberculosis

  2012cites this paper
• Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker

  2012cites this paper
• EVALUATION OF ISONIAZID PREVENTIVE THERAPY POLICY

  2012cites this paper
• YELLOW FEVER: THE CHALLENGES AHEAD IN INDIA

  2012cites this paper
• An update on vaccines for tuberculosis – there is more to it than just waning of BCG efficacy with time

  2012cites this paper
• Challenges of tuberculosis prevention through early detection of latent tuberculosis infection in new immigrants to the State of Kuwait

  2012cites this paper
• Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

  2012cites this paper
• Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety

  2012cites this paper
• Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

  2012cites this paper
• Recent developments in treatment of latent tuberculosis infection

  2011cites this paper
• Evidence-based clinical guidelines for immigrants and refugees

  2011cites this paper
• Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection.

  2011cites this paper
• Immunodiagnosis of Tuberculosis: a Dynamic View of Biomarker Discovery

  2011cites this paper
• Tuberculosis: evidence review for newly arriving immigrants and refugees

  2011cites this paper
• Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study

  2011cites this paper
• [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].

  2011cites this paper
• Prevalence of latent infection with Mycobacterium tuberculosis in Mazowieckie province using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10

  2011cites this paper
• Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?

  2011cites this paper
• Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders

  2011cites this paper
• Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions

  2010cites this paper